Business Health & beauty Paid
Pharmena’s molecule may combat coronavirus infection
20:14
WSE-listed biotechnology company Pharmena Group announced the potential impact of 1-MNA on the effects of SARS-Cos-2 infection. The authors of the latest scientific work published in Cell Death & Differentiation suggest, among others that vitamin B3 supplementation may be useful during the treatment of patients with COVID-19.
The latest scientific publication from March 2020 prepared by a group of Chinese and Italian scientists indicates that vitamin B3…
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
